Pace Life Sciences Acquires Meridian BioGroup
Aug 19, 2022
Expertise gained through the acquisition allows Pace to extend its capabilities to its clients. 08.19.22
Pace Life Sciences LLC , a full-service contract development and manufacturing organization (CDMO) and subsidiary of Pace Science and Technology Company, has acquired Meridian BioGroup, which specializes in bringing industry experts from regulatory affairs, quality, validation, and related backgrounds to meet its clients' needs in FDA-regulated environments. "Our clients value our technical expertise and commitment to supporting them in rapidly advancing their programs through the clinic and onto commercialization," said Eric Roman, CEO of Pace. "The acquisition of Meridian BioGroup adds an array of strategic services to our portfolio to further help clients with regulatory guidance and strategy, and to help them develop and maintain biopharmaceutical operations and quality management systems that meet regulatory requirements."
Quality system development and assessment of existing quality systems. Remediation of audit or inspection findings. Validation master planning. Computer system validation.